Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation

被引:7
作者
Chrysoula Pipili [1 ]
Evangelos Cholongitas [2 ]
机构
[1] Department of Nephrology, Laiki Merimna,17343 Athens, Greece
[2] 4~(th) Department of Internal Medicine,Medical School of Aristotle University, Hippokration GeneralHospital of Thessaloniki, 54642 Thessaloniki, Greece
关键词
Liver transplantation; Kidney transplanta-tion; Hepatitis C; Hepatitis B; Recurrence;
D O I
暂无
中图分类号
R512.6 [病毒性肝炎];
学科分类号
100401 ;
摘要
New nucleos(t)ide analogues(NAs) with high genetic barrier to hepatitis B virus(HBV) resistance(such as entecavir, tenofovir) have improved the prognosis of patients with HBV decompensated cirrhosis and have prevented HBV recurrence after liver transplantation(LT). NAs are considered the most proper approach for HBV infection in patients under renal replacement therapy but their doses should be adjusted according to the patient’s creatinine clearance. In addition, physi-cians should be aware of the potential nephrotoxicity. However, patients with chronic hepatitis C and decom-pensated cirrhosis can receive only one therapeutic option before LT, as well as for Hepatitis C virus(HCV) recurrence after LT, which is the combination of sub-cutaneous Peg-IFN and ribavirin. Generally, therapy for HCV after renal transplantation should be avoided. Although the optimal antiviral therapy for HCV infec-tion has not been established, attention has turned to a new, oral direct acting antiviral treatment which marks a promising strategy in prognosis and in amelioration of these diseases.
引用
收藏
页码:315 / 325
页数:11
相关论文
共 81 条
[21]  
K.K. Sureshkumar,N.L. Thai,R.J. Marcus.Kidney Transplantation in Hepatitis C-Positive Recipients: Does Type of Induction Influence Outcomes?[J].Transplantation Proceedings,2012(5)
[22]   Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation [J].
Cholongitas, E. ;
Vasiliadis, T. ;
Antoniadis, N. ;
Goulis, I. ;
Papanikolaou, V. ;
Akriviadis, E. .
TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (05) :479-487
[23]  
R. Perrillo,M. Buti Ferret,F. Durand,M. Charlton,A. Gadano,G. Cantisani,K. Brown,W. Hu,C. Llamoso.535 SAFETY AND EFFICACY OF ENTECAVIR IN PATIENTS RECEIVING LIVER TRANSPLANT DUE TO CHRONIC HEPATITIS B[J].Journal of Hepatology,2012
[24]  
Elisabetta Loggi,Lorenzo Micco,Giorgio Ercolani,Alessandro Cucchetti,Florian K. Bihl,Gian Luca Grazi,Stefano Gitto,Andrea Bontadini,Mauro Bernardi,Paolo Grossi,Alessandro Nanni Costa,Antonio Daniele Pinna,Christian Brander,Pietro Andreone.Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool[J].Journal of Hepatology,2011(3)
[25]  
H. L.Y. Chan,Y. C. Chen,E. J. Gane,S. K. Sarin,D. J. Suh,T. Piratvisuth,B. Prabhakar,S. G. Hwang,G. Choudhuri,R. Safadi,T. Tanwandee,A. Chutaputti,C. Yurdaydin,W. Bao,C. Avila,A. Trylesinski.Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment‐na?ve patients with HBV‐related decompensated cirrhosis[J].Journal of Viral Hepatitis,2012(10)
[26]   UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients [J].
Ramachandran, P. ;
Fraser, A. ;
Agarwal, K. ;
Austin, A. ;
Brown, A. ;
Foster, G. R. ;
Fox, R. ;
Hayes, P. C. ;
Leen, C. ;
Mills, P. R. ;
Mutimer, D. J. ;
Ryder, S. D. ;
Dillon, J. F. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (06) :647-662
[27]  
DidierSamuel.Hepatitis C virus treatment pre‐ and post‐liver transplantation[J].Liver Int,2011
[28]   Liver transplantation and hepatitis C [J].
Rubin, A. ;
Aguilera, V. ;
Berenguer, M. .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (12) :805-812
[29]   Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation [J].
Fung, James ;
Cheung, Cindy ;
Chan, See-Ching ;
Yuen, Man-Fung ;
Chok, Kenneth S. H. ;
Sharr, William ;
Dai, Wing-Chiu ;
Chan, Albert C. Y. ;
Cheung, Tan-To ;
Tsang, Simon ;
Lam, Banny ;
Lai, Ching-Lung ;
Lo, Chung-Mau .
GASTROENTEROLOGY, 2011, 141 (04) :1212-1219
[30]   Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B [J].
Heathcote, E. Jenny ;
Marcellin, Patrick ;
Buti, Maria ;
Gane, Edward ;
De Man, Robert A. ;
Krastev, Zahary ;
Germanidis, George ;
Lee, Samuel S. ;
Flisiak, Robert ;
Kaita, Kelly ;
Manns, Michael ;
Kotzev, Iskren ;
Tchernev, Konstantin ;
Buggisch, Peter ;
Weilert, Frank ;
Kurdas, Oya Ovunc ;
Shiffman, Mitchell L. ;
Trinh, Huy ;
Gurel, Selim ;
Snow-Lampart, Andrea ;
Borroto-Esoda, Katyna ;
Mondou, Elsa ;
Anderson, Jane ;
Sorbel, Jeff ;
Rousseau, Franck .
GASTROENTEROLOGY, 2011, 140 (01) :132-143